Index Catalog // Hyrax

Filtragem por: Contributor Hu, Mengjie Study Program Molecular Medicine Study Program (MolMed)

Descrição:	Background BRAF mutations are common in melanoma, with more than 50% harboring activating BRAF mutations. Though BRAF inhibitors are highly efficacious for nearly half of patients with this BRAF-mutant melanoma, many developing secondary...
Data Criada:	August 1-2, 2024

Filtre sua busca